OUR MOTIVATION
The cost to develop a single drug from invention to pharmacy shelves is estimated around $2.7 billion, according to Forbes in 2017. Even with this staggering number, 90% of drugs don’t make it to market because they are deemed unsafe or ineffective. We hope to change this. As a team, Syroto Bioprinters offers affordable, easy to use, and efficient printers that can print 3D cell matrices used for drug development. More realistic cell models allow for better representation of the human body and allow for accurate results from each drug regarding its effects on patients.
OUR PRODUCT
Syroto Bioprinters is developing cutting-edge customizable 3D bioprinters designed to fast track pharmaceutical development. It’s modular design and rotating print head platform allow for interchangeable, material-specific syringe heads that can accommodate a variety of customer applications for diverse printing needs.
Printheads
Inkjet based
Pressure-assisted
Laser Assisted
Magic Mixer
Biomaterial Cartridges
Our cartridges allow for printing made easy. Just pop a pre-ordered cartridge into our bioprinter and let the printing begin. With a wide range of biomaterials and cell culture reagents, the possibilities are limitless.
Customizable Software
With customizable materials comes customizable software. Our easy to use customer interface allows a range of material characteristics, volumes and run patterns to give you the perfect print, every time.
Discovery Made Easy
Fast tracking pharmaceuticals means opening doors to more meaningful medicine
OUR TEAM
McKell Davis
Team Lead
Ethan Lieberman
Control Software
Sydney Minar
Marketing
Derek Lublin
Electronics
Alexander Schmidt
Mechanical Design
CONTACT US
OUR OFFICE
2400 Engineering Hall
University of California, Irvine
Irvine, CA 92691
CONTACT US